Collegium Pharmaceutical (COLL) PT Lowered to $48 at Barclays
Tweet
Share
E-mailGet Alerts COLL Hot Sheet
Price: $24.09 -2.11%
Rating Summary:
7 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Rating Summary:
7 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Join SI Premium – FREE
Barclays analyst Glen Santangelo lowered the price target on Collegium Pharmaceutical (NASDAQ: COLL) to $48.00 (from $56.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Designer Brands (DBI) PT Lowered to $6 at UBS
- Science Applications (SAIC) PT Raised to $123 at UBS
- Kepler Cheuvreux Upgrades Entain PLC (ENT:LN) (GMVHF) to Buy
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
